A RANDOMIZED TRIAL OF REALIGNMENT THERAPY FOR TREATMENT OF MEDIAL KNEE ARTHRITIS

治疗膝关节内侧关节炎的重新调整疗法的随机试验

基本信息

  • 批准号:
    7379493
  • 负责人:
  • 金额:
    $ 2.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-12-01 至 2006-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The medial compartment absorbs 60-70% of the force across the knee during weight bearing and, in part, because it is subjected to more stress than the lateral compartment, osteoarthritis affects the medial tibiofemoral compartment much more often than the lateral one in both men and women. Since involvement of this compartment is especially frequent, interventions whose goal is to realign the knee so as to reduce transarticular loading on the medical compartment, such as valgus bracing are sometimes used clinically. Despite knowing for many years that altering loads in patients with knee OA may be a safe, inexpensive and an effective modality of treatment, there have been few studies that have evaluated these therapies, and these studies are either small or have other methodologic limitations. The overall objective of this 3-year project is to determine whether the provision of realignment therapy in patients with medial knee OA relieves knee pain and improves function. We will test the hypothesis that compared to control treatment, the use of realignment therapy (valgus knee brace + motion control shoes + orthosis) is effective in medial knee OA. The specific aims are: a. To undertake a 16-week, randomized crossover clinical trial in patients with medial knee osteoarthritis to determine whether provision of realignment therapy leads to lower pain scores and improved function during the time of this treatment than during the use of a placebo treatment; b. To perform an open label follow-up study to track use and effectiveness of treatment. This project will be co-funded by Generation II, a knee bracing company.
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。在负重过程中,内侧间隙吸收膝关节60%-70%的力,部分原因是由于内侧间隙比外侧间隙承受更大的压力,骨关节炎对胫股内侧间隙的影响在男性和女性中都比外侧关节腔大得多。由于这一间隙的介入特别频繁,临床上有时会使用旨在重新调整膝关节以减少内科间隙的跨关节负荷的干预措施,如外翻支撑。尽管多年来人们知道改变膝骨性关节炎患者的负荷可能是一种安全、廉价和有效的治疗方式,但很少有研究评估这些治疗方法,而且这些研究要么规模较小,要么有其他方法学上的局限性。这个为期3年的项目的总体目标是确定在内侧膝关节骨性关节炎患者中提供重排治疗是否缓解了膝关节疼痛并改善了功能。我们将检验这一假设,即与对照治疗相比,使用重排疗法(外翻膝关节支架+运动控制鞋+矫形器)在膝关节内侧骨关节炎中有效。具体目标是:a.对膝关节内侧骨关节炎患者进行为期16周的随机交叉临床试验,以确定在此治疗期间,提供调整治疗是否比使用安慰剂治疗期间疼痛评分更低、功能改善;b.进行一项开放标签跟踪研究,以跟踪治疗的使用和效果。该项目将由第二代膝盖支撑公司共同出资。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David John HUNTER其他文献

David John HUNTER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David John HUNTER', 18)}}的其他基金

Discovery, Biology and Risk of Inherited Variants in Breast Cancer
乳腺癌遗传变异的发现、生物学和风险
  • 批准号:
    7933407
  • 财政年份:
    2010
  • 资助金额:
    $ 2.82万
  • 项目类别:
THERAPY FOR TREATMENT OF MEDIAL KNEE ARTHRITIS
治疗内侧膝关节炎的疗法
  • 批准号:
    7606239
  • 财政年份:
    2007
  • 资助金额:
    $ 2.82万
  • 项目类别:
GENETIC ANALYSIS AND SAMPLE HANDLING
遗传分析和样品处理
  • 批准号:
    7072376
  • 财政年份:
    2004
  • 资助金额:
    $ 2.82万
  • 项目类别:
Folate, 1-Carbon Nutrients, Gene Variants & Colon Cancer
叶酸、1-碳营养素、基因变异
  • 批准号:
    7119203
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:
Fenoldopam: Effect and Contrast-Induced Renal Impairment
非诺多泮:效果和对比剂引起的肾损伤
  • 批准号:
    7041937
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:
Folate, 1-Carbon Nutrients, Gene Variants & Colon Cancer
叶酸、1-碳营养素、基因变异
  • 批准号:
    6801920
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
表征乳腺癌和前列腺癌的遗传易感性;
  • 批准号:
    7502076
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
表征乳腺癌和前列腺癌的遗传易感性;
  • 批准号:
    7658858
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:
Breast & Prostate Cancer & Hormone-Related Gene Variants
胸部
  • 批准号:
    7097455
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:
Breast & Prostate Cancer & Hormone-Related Gene Variants
胸部
  • 批准号:
    6953593
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:

相似国自然基金

相似海外基金

A mobile health solution in combination with behavioral change approach to improve vaccination coverage and timeliness in Bangladesh: A cluster randomized control trial
移动健康解决方案与行为改变方法相结合,以提高孟加拉国的疫苗接种覆盖率和及时性:集群随机对照试验
  • 批准号:
    24K20168
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
  • 批准号:
    23K24566
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
High Performance Reefable Wingsail Rig Design and Pre-deployment Trial
高性能可折叠翼帆装置设计和预部署试验
  • 批准号:
    10092779
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Collaborative R&D
Pulmonary rehabilitation delivered in low resource settings for people with chronic respiratory disease: a 3-arm assessor-blind implementation trial
在资源匮乏的环境中为慢性呼吸道疾病患者提供肺康复:一项三臂评估者盲法实施试验
  • 批准号:
    MR/Y004809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Research Grant
Memory Reshaping for Depression: A Remote Digital Randomised Controlled Feasibility Trial
抑郁症记忆重塑:远程数字随机控制可行性试验
  • 批准号:
    MR/Y008545/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Research Grant
Adaptive platform trialを用いた臨床研究基盤構築によるARDSの人工呼吸戦略の検討
通过使用自适应平台试验构建临床研究基础设施来检查 ARDS 的人工通气策略
  • 批准号:
    24K12148
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
  • 批准号:
    2898794
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Studentship
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
  • 批准号:
    10103126
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    EU-Funded
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
  • 批准号:
    10110442
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    EU-Funded
A benefit-risk trial of 1-month rifapentine and isoniazid to prevent tuberculosis and reduce morbidity in people with non-communicable multimorbidity
一项为期 1 个月的利福喷汀和异烟肼预防结核病并降低非传染性多病患者发病率的效益风险试验
  • 批准号:
    MR/Y004914/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.82万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了